ADDvise wins public tender worth 7 MSEK
ADDvise Group AB’s (publ) subsidiary Hettich Labinstrument has received an allocation decision from Stockholms Läns Landsting regarding a delivery of blood collection products. The products are primarily vacuum tubes and safety products and the delivery start is in October 2017. The contract will run for two years with the possibility of a one year extension for up to two years. The order is worth approximately 7 MSEK the first two years and the agreement has a standstill period until June 14th 2017, then Hettich has the right to sign the agreement with SLL.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
This information is by ADDvise required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on June 5, 2017 at 10
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, 08-503015 50, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com .